Borderline resectable pancreatic cancer: pushing the technical limits of surgery
Katz, M.H.G.; Ahmad, S.; Nelson, H.
Bulletin of the American College of Surgeons 98(1): 61-63
2013
ISSN/ISBN: 0002-8045 PMID: 23359915 Document Number: 668476
Document emailed within 1 workday
Related Documents
Shah, A.P.; Strauss, J.B.; Leslie, W.T.; Shah, A.; Mahon, B.; Abrams, R.A. 2008: Management of a patient with borderline resectable pancreatic cancer. Case report and review Oncology 22(13): 1524-1529Mataki, Y.; Shinchi, H.; Maemura, K.; Kurahara, H.; Kawasaki, Y.; Desaki, R.; Ueno, S.; Sakoda, M.; Iino, S.; Higashi, M.; Takao, S.; Natsugoe, S. 2013: Examination of resectable and borderline pancreatic cancer treated with neoadjuvant chemoradiation therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1637-1640
Nakayasu, Y.; Shiozawa, S.; Usui, T.; Kuhara, K.; Kono, T.; Shimojima, Y.; Tsuchiya, A.; Miyauchi, T.; Asaka, S.; Yamaguchi, K.; Yokomizo, H.; Shimakawa, T.; Naritaka, Y. 2018: A Case of Borderline Resectable Pancreatic Head Cancer Treated by Curative Resection after Chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(13): 2306-2308
Huang, L. 2018: Neoadjuvant Chemoradiotherapy Followed by Surgery versus Surgery Alone for Resectable Pancreatic Carcinoma American surgeon 84(12): e567-e574
Berlin, J.D.; Rothenberg, M. 2001: Chemotherapy for resectable and advanced pancreatic cancer Oncology 15(10): 1241-1249; 1254; Discussion: 1254-1264
Philip, P.A. 2011: Are we ready for neoadjuvant therapy in potentially resectable pancreatic cancer? Oncology 25(2): 189-190; 192
Miyamoto, T.; Inoue, M.; Tanemura, M.; Yamaguchi, M.; Irei, T.; Tamaru, K.; Seo, S.; Misumi, T.; Shimizu, W.; Suzuki, T.; Onoe, T.; Sudo, T.; Shimizu, Y.; Hinoi, T.; Tashiro, H. 2018: A Resectable Case of TS-1 Therapy Useful in Distinguishing Primary Lung Cancer from Lung Metastases of Pancreatic Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(1): 88-90
Skarin, A.; Malcolm, A.; Leslie, N.; Oliynyk, P.; Overholt, R.; Frei, E. 1985: Chemotherapy (CAP) prior to radiotherapy (RT) and surgery in marginally resectable stage IIi M0 non-small cell lung cancer Progress in Clinical and Biological Research 201: 127-132
Neoptolemos, J.P.; Baker, P.; Beger, H.; Link, K.; Pederzoli, P.; Bassi, C.; Dervenis, C.; Friess, H.; Büchler, M. 1997: Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 21(2): 97-104
Goldberg, R.M.; Fleming, T.R.; Tangen, C.M.; Moertel, C.G.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A. 1998: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group Annals of Internal Medicine 129(1): 27-35
Barbuscia, M.A.; Cingari, E.A.; Torchia, U.; Querci, A.; Lemma, G.; Ilacqua, A.; Caizzone, A.; Sanò, A.; Fabiano, V. 2013: Indications for and limits of conservative surgery in breast cancer Il Giornale di Chirurgia 34(3): 90-94
Motoi, F.; Kawaguchi, K.; Aoki, T.; Kudo, K.; Yabuuchi, S.; Fukase, K.; Mizuma, M.; Sakata, N.; Otsutomo, S.; Morikawa, T.; Hayashi, H.; Nakagawa, K.; Okada, T.; Yoshida, H.; Naitoh, T.; Katayose, Y.; Egawa, S.; Unno, M. 2013: Efficacy of neoadjuvant chemotherapy for resectable pancreatic carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1632-1636
Kawamura, I.; Rai, N.; Kawate, T.; Yoneyama, K.; Hayata, Y. 1981: Problem of lung cancer surgery in old age--safety limits and postoperative care Kyobu Geka. Japanese Journal of Thoracic Surgery 34(6): 435-440
Coco, C.; Magistrelli, P.; Granone, P.; Netri, G.; Mattana, C.; Cogliandolo, S.; Carbone, L.; Picciocchi, A. 1995: Surgery of rectal cancer (technical observations) Rays 20(1): 112-119
Schlichting, E.; Clausen, O.P.; Hanssen, A.S.; Buanes, T.A. 1993: Ploidy and survival in resectable pancreatic cancers. A retrospective study over 9 years European Journal of Surgery 159(4): 229-233
Andrén-Sandberg, A.; Johansson, S. 1988: Surgery of pancreatic cancer in Sweden--where and how? Lakartidningen 85(13): 1150; 1152-1153
Lygidakis, N.J.; Papadopoulou, P. 1995: Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer? Hepato-Gastroenterology 42(5): 587-596
Wittrin, G.; Jost, J.O.; Clemens, M.; Arndt, M. 1981: Pancreatic duct occlusion following duodeno-pancreatectomy in cancer surgery Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 52(3): 157-159
Tarazov, P.G.; Granov, D.A.; Polikarpov, A.A.; Kozlov, A.V.; Popov, S.A.; Shapoval, S.V.; Gulo, A.S. 2012: Roentgenoendovascular hemostasis of arterial bleeding after major surgery for pancreatic cancer Vestnik Khirurgii Imeni I. I. Grekova 171(1): 24-30
Kimura, W. 2007: Pancreatic cancer--characteristics of the Japanese Guidelines for the Diagnosis and Treatment of Pancreatic Cancer and my opinion on this subject Nihon Geka Gakkai Zasshi 108(5): 267-272